Latest News About - Immunoglobulin

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Friday, August 7, 2020

7:43:00 PM CEST

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
gl
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
ky
lb
lo
lt
lv
mk
ml
mn
ms
mt
nl
no
pap
pl
ps
pt
ro
ru
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Most reported countries (24h)

Theme countries

AlertLevel (24h)

Alert level graph

 Previous 14 days average

Alert level:
 high   medium   low

Quotes... Extracted quotes

Klaas Bakker says: "Today we embarked upon the next phase of our journey with melflufen as we initiated patient enrollment in our phase 1/2 AL amyloidosis study," External link

prnewswire Friday, August 7, 2020 8:20:00 AM CEST

Randeep Guleria said: "However, this is just an interim analysis and we need to do a more detailed evaluation to see if any sub-group may benefit from plasma therapy," External link

livemint Thursday, August 6, 2020 1:38:00 PM CEST

Randeep Guleria said: "However, this is just an interim analysis and we need to do a more detailed evaluation to see if any sub-group may benefit from plasma therapy," External link

ndtvnews Thursday, August 6, 2020 1:18:00 PM CEST

Paul Chaplin stated: “At Bavarian Nordic, we have a compelling infrastructure that aligns with the critical vaccine market needs from basic research and development to commercial operations, manufacturing and distribution,” External link

4-traders Wednesday, August 5, 2020 2:43:00 PM CEST

Chen Dong said: “Our work has provided a basis for further analysis of protective immunity and for understanding the mechanism underlying the development of Covid-19, especially in severe cases. It also has implications for designing an effective vaccine to protect against infection,” External link

qnewshub Wednesday, August 5, 2020 12:31:00 AM CEST

Marcin Pirog tells: “Our drug is Immunoglobulin Anti-SARS-CoV-2 – a protein produced by plasma cells,” External link

emerging-europe Tuesday, August 4, 2020 10:40:00 AM CEST

Marcin Pirog explains: “We are completing the collection of plasma from Covid-19-recovered donors to produce the first batch of our drug. Depending on the titre we will produce 2,000-4,000 ampules for clinical trials,” “Production should start by mid-August and the product shall be delivered to hospitals running trials by the end of September” External link

emerging-europe Tuesday, August 4, 2020 10:40:00 AM CEST

Marcin Pirog says: “We produced dozens of different vaccines, serums, and immunoglobulins to save lives and make people feel safe for several generations,” External link

emerging-europe Tuesday, August 4, 2020 10:40:00 AM CEST

John Tsai said: “We are pleased that Kymriah is showing meaningful results and may provide a potentially definitive treatment option for patients with relapsed and refractory follicular lymphoma,” External link

4-traders Tuesday, August 4, 2020 7:15:00 AM CEST

Francis Collins uvedl: „Proběhlá studie zodpovídá alespoň jednu ze stávajících otázek a přináší tolik potřebovanou jasnou odpověď, která oživuje entuziasmus pro testování protilátek SARS-CoV-2 v populaci,” External link

novinky Sunday, May 17, 2020 6:15:00 AM CEST

Tufan Tukek dedi: "Aslında antikor testleri, koronavirüs ile birlikte hayatımıza girdi. Pandeminin ilk zamanlarında hızlı antikor tanı kitleri adı altında oldukça yüksek miktarlarda hastanelere dağıtıldı. Bize de o zamanlar 300 kadar kit gelmişti hatta. Ancak daha sonra hem Sağlık Bakanlığı'nın hem de bizim yapmış olduğumuz değerlendirmelerde, PCR testi pozitif olanlarda bile bu kitlerin negatif sonuç verdiği görülünce, bu kitlerin tanıdaki doğruluk payının çok da düşük olduğu anlaşıldı ve bunların kullanılmaması kararı alındı. Sonraki süreçte, 3 ay 4 aylık bir süre içerisinde dünyada da birçok çalışma yapan şirket vardı bu antikor testleri konusunda. Oldukça geliştirildi ve yeni nesil kitler artık yüzde 100'e yakın doğruluk payı ile sonuç veriyor. Duyarlılığı daha yüksek. Bu nedenle bu testi yaptırmak isteyenlerin testi yapan kurumun kitlerini sorgulaması gerekiyor. Şayet eski nesil kitlerden kullanılıyorsa çok da güvenli değil" External link

haber-mynet Thursday, June 4, 2020 8:31:00 AM CEST

Most associated names

Daily number of articles in this category

Trend data not available for this selection.